C. diff infection study for healthy volunteers
Treatments studied
Part of Infections clinical trials.
This study gives healthy volunteers a specially prepared dose of Clostridioides difficile (C. diff), a bacteria that can cause diarrhea and gut problems, to learn how the infection develops. By participating, you may help researchers better understand and prevent C. diff infections in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old and in good health.
- You have a body mass index (BMI) between 18.0 and 30.0.
- You have not taken antibiotics by mouth or in your veins in the last 3 months.
- You have not been hospitalized in the last 3 months and do not live with or have close contact with someone who is often hospitalized.
- You do not have any chronic gut conditions, such as inflammatory bowel disease or a history of bowel surgery.
- You are willing to avoid close contact with vulnerable people (like infants, pregnant women, or the elderly) for a period during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at levels of C. diff toxins in stool after standard antibiotic treatment. It aims to understand how toxins change during recovery, which may help improve future treatments for C. diff infections.
This trial tests an experimental treatment called CMTS0929 for people with a C. difficile infection that is causing diarrhea. The treatment is given through a tube placed through the nostril or mouth into the intestine, and the study will see if it is safe and helpful.
This trial tests a treatment called washed microbiota transplantation (WMT) for people with a C. diff infection that causes diarrhea. WMT uses processed donor bacteria to help restore healthy gut balance and fight the infection.
This Phase 1 study tests defined fecal microbiota (healthy gut bacteria) given to people with C. difficile diarrhea that didn’t go away or came back soon after antibiotics. It may help by restoring a healthier balance of gut bacteria so the infection can stop recurring.
This trial tests a new medicine made from a weakened yeast that is designed to fight a bacteria called C. diff, which can cause severe diarrhea. It's a first-in-human safety study, so the main goal is to see if the medicine is safe and how your body handles it.
This trial compares three treatments for a severe diarrhea infection called C. diff: a fecal transplant (putting healthy donor stool into your gut), a newer antibiotic called fidaxomicin, and an older antibiotic called vancomycin. The goal is to see which works best and prevents the infection from coming back.
Hear when a new C. Difficile trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.